Antibodies in Repeated Influenza Vaccination (ARIVA) Study
Last updated on July 2021Recruitment
- Recruitment Status
- Enrolling by invitation
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Vaccine Response Impaired
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04059991
- Collaborators
- University of Oslo
- University of Oxford
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Investigators
- Principal Investigator: Christoph T Berger, MD University Hospital Basel, Medical Outpatient Clinic